γ-Herpes virus-68, but not Pseudomonas aeruginosa or influenza A (H1N1), exacerbates established murine lung fibrosis

Am J Physiol Lung Cell Mol Physiol. 2014 Aug 1;307(3):L219-30. doi: 10.1152/ajplung.00300.2013. Epub 2014 May 30.

Abstract

Patients with idiopathic pulmonary fibrosis (IPF) often do worse following infection, but the cause of the decline is not fully understood. We previously demonstrated that infection with a murine gamma herpes virus (γHV-68) could exacerbate established lung fibrosis following administration of fluorescein isothiocyanate (McMillan et al. Am J Respir Crit Care Med 177: 771-780, 2008). In the present study, we anesthetized mice and injected saline or bleomycin intratracheally on day 0. On day 14, mice were anesthetized again and infected with either a Gram-negative bacteria (Pseudomonas aeruginosa), or with H1N1 or γHV-68 viruses. Measurements were then made on days 15, 21, or 35. We demonstrate that infection with P. aeruginosa does not exacerbate extracellular matrix deposition post-bleomycin. Furthermore, fibrotic mice are effectively able to clear P. aeruginosa infection. In contrast, bleomycin-treated mice develop worse lung fibrosis when infected with γHV-68, but not when infected with H1N1. The differential ability of γHV-68 to cause increased collagen deposition could not be explained by differences in inflammatory cell recruitment or whole lung chemokine and cytokine responses. Alveolar epithelial cells from γHV-68-infected mice displayed increased expression of TGFβ receptor 1, increased SMAD3 phosphorylation, and evidence of apoptosis measured by cleaved poly-ADP ribose polymerase (PARP). The ability of γHV-68 to augment fibrosis required the ability of the virus to reactivate from latency. This property appears unique to γHV-68, as the β-herpes virus, cytomegalovirus, did not have the same effect.

Keywords: bacteria; collagen; fibrosis; lung; virus.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Apoptosis / drug effects
  • Bleomycin / adverse effects
  • Disease Models, Animal
  • Epithelial Cells / drug effects
  • Epithelial Cells / microbiology
  • Epithelial Cells / pathology
  • Epithelial Cells / virology
  • Herpesviridae / pathogenicity*
  • Inflammation / metabolism
  • Inflammation / microbiology
  • Inflammation / virology
  • Influenza A Virus, H1N1 Subtype / pathogenicity*
  • Lung / drug effects
  • Lung / metabolism
  • Lung / microbiology
  • Lung / virology
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Poly (ADP-Ribose) Polymerase-1
  • Poly(ADP-ribose) Polymerases / metabolism
  • Pseudomonas aeruginosa / pathogenicity*
  • Pulmonary Fibrosis / chemically induced
  • Pulmonary Fibrosis / metabolism
  • Pulmonary Fibrosis / microbiology*
  • Pulmonary Fibrosis / virology*
  • Smad3 Protein / metabolism
  • Transforming Growth Factor beta1 / metabolism

Substances

  • Smad3 Protein
  • Smad3 protein, mouse
  • Transforming Growth Factor beta1
  • Bleomycin
  • Parp1 protein, mouse
  • Poly (ADP-Ribose) Polymerase-1
  • Poly(ADP-ribose) Polymerases